rs147354818

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_005422.4(TECTA):ā€‹c.4720A>Gā€‹(p.Ile1574Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00154 in 1,614,236 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0012 ( 1 hom., cov: 33)
Exomes š‘“: 0.0016 ( 4 hom. )

Consequence

TECTA
NM_005422.4 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:5

Conservation

PhyloP100: 1.05
Variant links:
Genes affected
TECTA (HGNC:11720): (tectorin alpha) The tectorial membrane is an extracellular matrix of the inner ear that contacts the stereocilia bundles of specialized sensory hair cells. Sound induces movement of these hair cells relative to the tectorial membrane, deflects the stereocilia, and leads to fluctuations in hair-cell membrane potential, transducing sound into electrical signals. Alpha-tectorin is one of the major noncollagenous components of the tectorial membrane. Mutations in the TECTA gene have been shown to be responsible for autosomal dominant nonsyndromic hearing impairment and a recessive form of sensorineural pre-lingual non-syndromic deafness. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00861764).
BP6
Variant 11-121160165-A-G is Benign according to our data. Variant chr11-121160165-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 303027.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=4, Uncertain_significance=2}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00116 (176/152342) while in subpopulation NFE AF= 0.00181 (123/68036). AF 95% confidence interval is 0.00155. There are 1 homozygotes in gnomad4. There are 77 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 4 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TECTANM_005422.4 linkuse as main transcriptc.4720A>G p.Ile1574Val missense_variant 15/24 ENST00000392793.6 NP_005413.2
TBCEL-TECTANM_001378761.1 linkuse as main transcriptc.5677A>G p.Ile1893Val missense_variant 21/30 NP_001365690.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TECTAENST00000392793.6 linkuse as main transcriptc.4720A>G p.Ile1574Val missense_variant 15/245 NM_005422.4 ENSP00000376543 P4

Frequencies

GnomAD3 genomes
AF:
0.00116
AC:
176
AN:
152224
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000506
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00198
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00181
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.00118
AC:
296
AN:
251486
Hom.:
1
AF XY:
0.00121
AC XY:
165
AN XY:
135916
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.000983
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00263
Gnomad NFE exome
AF:
0.00170
Gnomad OTH exome
AF:
0.00163
GnomAD4 exome
AF:
0.00158
AC:
2306
AN:
1461894
Hom.:
4
Cov.:
32
AF XY:
0.00151
AC XY:
1095
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.000179
Gnomad4 AMR exome
AF:
0.000961
Gnomad4 ASJ exome
AF:
0.000115
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000580
Gnomad4 FIN exome
AF:
0.00279
Gnomad4 NFE exome
AF:
0.00181
Gnomad4 OTH exome
AF:
0.00134
GnomAD4 genome
AF:
0.00116
AC:
176
AN:
152342
Hom.:
1
Cov.:
33
AF XY:
0.00103
AC XY:
77
AN XY:
74502
show subpopulations
Gnomad4 AFR
AF:
0.000505
Gnomad4 AMR
AF:
0.000653
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00198
Gnomad4 NFE
AF:
0.00181
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.00147
Hom.:
0
Bravo
AF:
0.000922
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00163
AC:
14
ExAC
AF:
0.00126
AC:
153
EpiCase
AF:
0.00174
EpiControl
AF:
0.00184

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingGeneDxSep 25, 2020Observed in 0.1191% (337/282894 alleles) in large population cohorts (Lek et al., 2016) -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpOct 09, 2023- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 10, 2021The c.4720A>G (p.I1574V) alteration is located in exon 14 (coding exon 14) of the TECTA gene. This alteration results from a A to G substitution at nucleotide position 4720, causing the isoleucine (I) at amino acid position 1574 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Autosomal recessive nonsyndromic hearing loss 21 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJun 24, 2017p.Ile1574Val in exon 14 of TECTA: This variant is not expected to have clinical significance due to a lack of conservation across species, including mammals. Of note, Golden hamster, cat, rabbit, and four other mammals have a valine (Val) a t this position despite high nearby amino acid conservation. It has also been i dentified in 0.2% (63/25794) of Finnish chromosomes and 0.2% (221/126732) of Eur opean chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broa dinstitute.org; dbSNP rs147354818). -
Autosomal dominant nonsyndromic hearing loss 12 Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
TECTA-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJun 25, 2019This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
7.4
DANN
Benign
0.38
DEOGEN2
Benign
0.073
T;.;T
Eigen
Benign
-0.78
Eigen_PC
Benign
-0.58
FATHMM_MKL
Benign
0.49
N
LIST_S2
Benign
0.76
.;T;T
M_CAP
Benign
0.0022
T
MetaRNN
Benign
0.0086
T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
-0.20
N;.;N
MutationTaster
Benign
0.95
N;N
PrimateAI
Benign
0.42
T
PROVEAN
Benign
0.22
N;.;N
REVEL
Benign
0.061
Sift
Benign
0.72
T;.;T
Sift4G
Benign
1.0
T;.;T
Polyphen
0.0010
B;.;B
Vest4
0.23
MVP
0.53
MPC
0.27
ClinPred
0.017
T
GERP RS
1.2
Varity_R
0.044
gMVP
0.085

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs147354818; hg19: chr11-121030874; API